Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention

Maturitas

Volumn 44, Issue 4, 2003, Pages 299-305

  Lilliu, Hervé ^a   Pamphile, Raymond ^b   Chapuy, Marie Claire ^c   Schulten, Jeltje ^b   Arlot, Monique ^c   Meunier, Pierre J ^c  

^a CLP Santé H L   (France)

^b Merck KGaA France   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Calcium; Cost effectiveness; Elderly; Hip fracture cost; Supplementation; Vitamin D3 (cholecalciferol)

Indexed keywords

CALCIUM PHOSPHATE; COLECALCIFEROL; BETA-TRICALCIUM PHOSPHATE;

ARTICLE; BELGIUM; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; FRANCE; GERMANY; HIP FRACTURE; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; NETHERLANDS; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SPAIN; SWEDEN; UNITED KINGDOM; VITAMIN SUPPLEMENTATION; AGED; DRUG COMBINATION; DRUG COST; ECONOMICS; EUROPE; HEALTH CARE COST; POSTMENOPAUSE OSTEOPOROSIS;

AGED; CALCIUM PHOSPHATES; CHOLECALCIFEROL; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG THERAPY, COMBINATION; EUROPE; FEMALE; HEALTH CARE COSTS; HIP FRACTURES; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0037466317     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(03)00038-0     Document Type: Article

References (29)

1. Chapuy MC, Meunier PJ. Pathophysiology and prevention of hip fractures in elderly people, In: Meunier Pierre J, Dunitz M, editors. Osteoporosis: Diagnosis and Management, London 1998; p. 191-209.
2. Arden N, Cooper C. Present and future of osteoporosis: epidemiology, In: Meunier Pierre J, Dunitz M, editors. Osteoporosis: Diagnosis and Management. London 1998; p. 1-16.
3. Praemer A., Furner S., Rice D.P. Musculoskeletal conditions in the United States. 1992;145-170 American Academy of Orthopaedic Surgeons, Rosemont, IL.
4. Jensen J.S., Bagger J. Long-term social prognosis after hip fractures. Acta Orthop. Scand. 53:1982;97-101.
5. 3 and calcium to prevent hip fractures in elderly women. New Engl. J. Med. 327:1992;1637-1642.
6. Chapuy M.C., Arlot M.E., Delmas P.D., et al. Effect of calcium and cholecalciferol treatment for 3 years on hip fractures in elderly women. Br. Med. J. 308:1994;1081-1082.
7. 3 in elderly women. J. Biomed. Mater. Res. 8:(1):1993;A25.
8. Autier P., Haentjens P., Bentin J., et al. Costs induced by hip fractures: a prospective controlled study in Belgium. Osteoporosis Int. 11:2000;373-380.
9. Maurel F., Lévy E., Le Pen C. Hospital cost of osteoporotic fractures in France. J. d'éonomie médicale. 16:(2):1998;99-108.
10. SESI. Ministére de l'Emploi et de la Solidarité. France 1999.
11. Pientka L., Friedrich C. The costs of hip fracture in Germany: a prospective evaluation. Z. Gerontol. Geriatr. 32:(5):1999;326-332.
12. De Laet C., Van Hout B., Burger H., et al. Incremental cost of medical care after hip fracture and first vertebral fracture: the Rotterdam study. Osteoporosis Int. 10:1999;66-72.
13. Arboleya L.R., Castro M.A., Bartolome E., et al. Epidemiology of the osteoporotic fracture of the hip in the province of Palencia. Rev. Clin. Esp. 198:(3):1998;186-187.
14. Jönsson B., Christiansen C., Johnell O., et al. Cost-effectiveness of fracture prevention in established osteoporosis. Osteoporosis Int. 5:1995;136-142.
15. Dolan P., Torgerson D.J. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporosis Int. 8:(6):1998;611-617.
16. NIH. Consensus Development Panel on Optimal Calcium Intake. NIH Consensus Conference: Optimal Calcium Intake, J. Am. Med. Assoc. 1994; 272:1942-948.
17. Heaney RP, Burckhardt P. Nutrition and bone health in Nutritional Aspects of Osteoporosis '94, Ares-Serono Symposia series challenges of modern medicine, 1995 7:419-24.
18. Togerson D.J., Kanis J.A. Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium. Q. J. Med. 88:1995;135-139.
19. Bendich A., Leader S., Muhuri P. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits. Clin. Ther. 21:(6):1999;1058-1072.
20. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22:2001;477-501.
21. Ellfors J., Allander E., Kanis J.A., et al. The variable incidence of hip fracture in Southern Europe: the MEDOS study. Osteoporosis Int. 4:1994;253-263.
22. Cruz A.A., Moreiras Valera D., Van Straveren W.A., et al. Intake of vitamins and minerals. Eur. J. Clin. Nutr. 45:(Suppl. 3):1990;121-138.
23. Ostéoporose: Stratégies de prévention et de traitement, Expertise Collective INSERM. eds. 1996: 75-94.
24. Van der Wielen R.P., Lowik M.R.H., Van der Berg H., et al. Serum 25 OHD concentrations among elderly people in Europe. Lancet. 346:1995;207-210.
25. Mc Kenna M.J. Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 93:1992;69-77.
26. 3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II Study. Osteoporosis Int. 13:2002;257-264.
27. Lips P., Graafmans W.C., Ooms M.E., et al. Vitamin D supplementation and fracture incidence in elderly persons. Ann. Intern. Med. 124:1996;400-406.
28. Meyer HE, Smedshaug GB, Kvaavik et al. Can vitamin supplementation reduce the risk of fracture in the elderly? A randomized controlled trial, J. Bone Res. 2002; 17:709-15.
29. Dawson-Hughes B., Harris S.S., Krall E.A., et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New Engl. J. Med. 337:1997;670-676.